Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients

Emerging Biomarkers for the Selection of Advanced NSCLC-Affected Immunotherapy Patients

Immunotherapy in the form of ICIs has revolutionized advanced NSCLC treatment algorithms, with ICI-containing combination treatments being the latest addition to approved regimens. However, PD-L1 still represents the only routinely assessed and validated biomarker apart from genetic drivers testing,...

Full description

Saved in:
Bibliographic Details
Main Authors: Luigi Della Gravara (Author), Ciro Battiloro (Author), Antonietta Letizia (Author), Rosa Cantile (Author), Vito D'Agnano (Author), Giacomo Sica (Author), Danilo Rocco (Author)
Format: Book
Published: MDPI AG, 2021-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items